SIDE EFFECTS: Pain/redness at the injection site, mild diarrhea, itching, or a feeling of swelling all over the body may occur
Take home message CagriSema is an investigational once-a-week injection from Novo Nordisk that combines cagrilintide and semaglutide
This combination is highly prized for its targeted, pulsatile stimulation of endogenous Growth Hormone (GH) release, making it a crucial subject for studies targeting tissue repair, body composition, and overall recovery
There can be also other complications, such as an increase in fetal abnormalities
If I would do leg day, a lot of times I would struggle to walk
As a Doctor of Osteopathic Medicine with extensive training in functional medicine, Dr